Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Psycheceutical Bioscience Inc. Stock Analysis BWVI
United States N/A Nano Cap Psycheceutical Bioscience, Inc. engages in psychedelic medicine and represents the potential for major progress in the area of mental health treatment. The company is headquartered in Fleming Island, Florida and currently employs 28 full-time employees. The company went IPO on 2007-05-25. The Company’s patented NeuroDirect non-systemic delivery technology is designed to deliver neuro-active compounds directly into the nerve tissue via topical application at the back of the neck. The delivery system is intended to enable immediate and sustained delivery, safe dosage control, and consistent results-while avoiding the GI tract and any unwanted side effects and toxicity. The company has designed a product that improves the quality of life for those suffering from Post-Traumatic Stress Disorder (PTSD) and Chronic Regional Pain Syndrome (CRPS). Its pipeline program includes the PSY-007-KETAMINE. The company focuses on commercializing its precision dosing technologies to provide affordable, life-saving treatments to anyone suffering from mental health disorders or central nervous system diseases.
Read More Psycheceutical Bioscience Inc (BWVI) Chart
Key Statistics of Psycheceutical Bioscience Inc (BWVI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
3000.00P/E Ratio (TTM)
-52 Week Range
Market Cap
121.12KAvg. Volume
38.52KDividend Yield
-Financial Metrics & Statements of Psycheceutical Bioscience Inc (BWVI)
FAQ's for Psycheceutical Bioscience Inc (BWVI)
- According to Musaffa’s Shariah screening methodology, Psycheceutical Bioscience Inc (BWVI) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Psycheceutical Bioscience Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Psycheceutical Bioscience Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Psycheceutical Bioscience Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Psycheceutical Bioscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Psycheceutical Bioscience Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.